Veritable’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-48,224
| Closed | -$3.33M | – | 185 |
|
|
2023
Q2 | $3.33M | Buy |
48,224
+1,929
| +4% | +$137K | 0.05% | 164 |
|
|
2023
Q1 | $3.44M | Sell |
46,295
-1,884
| -4% | -$158K | 0.06% | 164 |
|
|
2022
Q4 | $4.49M | Buy |
48,179
+2,082
| +5% | +$201K | 0.08% | 130 |
|
|
2022
Q3 | $4.4M | Sell |
46,097
-550
| -1% | -$54.4K | 0.09% | 123 |
|
|
2022
Q2 | $4.32M | Sell |
46,647
-28
| -0.1% | -$2.73K | 0.08% | 136 |
|
|
2022
Q1 | $4.72M | Sell |
46,675
-2,361
| -5% | -$248K | 0.07% | 144 |
|
|
2021
Q4 | $5.06M | Sell |
49,036
-213
| -0.4% | -$19.7K | 0.07% | 132 |
|
|
2021
Q3 | $4.18M | Buy |
49,249
+1,237
| +3% | +$104K | 0.07% | 145 |
|
|
2021
Q2 | $4.01M | Buy |
48,012
+933
| +2% | +$76.4K | 0.06% | 154 |
|
|
2021
Q1 | $3.54M | Buy |
47,079
+198
| +0.4% | +$14.4K | 0.06% | 157 |
|
|
2020
Q4 | $3.2M | Sell |
46,881
-3,270
| -7% | -$213K | 0.06% | 157 |
|
|
2020
Q3 | $2.93M | Buy |
50,151
+326
| +0.7% | +$20.3K | 0.06% | 154 |
|
|
2020
Q2 | $3.24M | Sell |
49,825
-1,444
| -3% | -$90.9K | 0.07% | 133 |
|
|
2020
Q1 | $3.04M | Buy |
51,269
+483
| +1% | +$32.2K | 0.07% | 141 |
|
|
2019
Q4 | $3.77M | Buy |
50,786
+3,796
| +8% | +$267K | 0.07% | 155 |
|
|
2019
Q3 | $2.96M | Buy |
46,990
+157
| +0.3% | +$9.3K | 0.06% | 168 |
|
|
2019
Q2 | $2.55M | Buy |
46,833
+2,723
| +6% | +$147K | 0.05% | 187 |
|
|
2019
Q1 | $2.38M | Sell |
44,110
-2,776
| -6% | -$171K | 0.05% | 189 |
|
|
2018
Q4 | $3.07M | Buy |
46,886
+6,623
| +16% | +$494K | 0.07% | 152 |
|
|
2018
Q3 | $3.17M | Sell |
40,263
-179
| -0.4% | -$12.8K | 0.06% | 162 |
|
|
2018
Q2 | $2.6M | Sell |
40,442
-4,582
| -10% | -$302K | 0.05% | 171 |
|
|
2018
Q1 | $2.8M | Buy |
45,024
+4,803
| +12% | +$345K | 0.06% | 168 |
|
|
2017
Q4 | $2.92M | Sell |
40,221
-14,438
| -26% | -$1.05M | 0.06% | 162 |
|
|
2017
Q3 | $4.45M | Sell |
54,659
-814
| -1% | -$64.4K | 0.09% | 129 |
|
|
2017
Q2 | $4.46M | Buy |
55,473
+15,162
| +38% | +$1.2M | 0.1% | 124 |
|
|
2017
Q1 | $3.16M | Buy |
40,311
+532
| +1% | +$42.5K | 0.08% | 151 |
|
|
2016
Q4 | $3.14M | Buy |
39,779
+1,597
| +4% | +$129K | 0.08% | 153 |
|
|
2016
Q3 | $3.4M | Buy |
38,182
+980
| +3% | +$92.5K | 0.09% | 136 |
|
|
2016
Q2 | $3.56M | Sell |
37,202
-1,073
| -3% | -$107K | 0.09% | 129 |
|
|
2016
Q1 | $3.97M | Buy |
38,275
+2,019
| +6% | +$196K | 0.1% | 121 |
|
|
2015
Q4 | $3.54M | Sell |
36,256
-193
| -0.5% | -$18.9K | 0.1% | 133 |
|
|
2015
Q3 | $3.52M | Buy |
36,449
+1,170
| +3% | +$123K | 0.1% | 132 |
|
|
2015
Q2 | $3.7M | Sell |
35,279
-77,004
| -69% | -$7.87M | 0.1% | 135 |
|
|
2015
Q1 | $11.6M | Buy |
112,283
+22,176
| +25% | +$2.24M | 0.24% | 65 |
|
|
2014
Q4 | $8.68M | Sell |
90,107
-7,915
| -8% | -$697K | 0.18% | 97 |
|
|
2014
Q3 | $7.8M | Buy |
98,022
+766
| +0.8% | +$60.4K | 0.17% | 100 |
|
|
2014
Q2 | $7.33M | Sell |
97,256
-36,369
| -27% | -$2.75M | 0.15% | 110 |
|
|
2014
Q1 | $10M | Sell |
133,625
-18,096
| -12% | -$1.28M | 0.22% | 79 |
|
|
2013
Q4 | $10.9M | Buy |
151,721
+27,704
| +22% | +$1.78M | 0.24% | 69 |
|
|
2013
Q3 | $7.04M | Sell |
124,017
-19,125
| -13% | -$1.14M | 0.16% | 104 |
|
|
2013
Q2 | $8.19M | Buy |
+143,142
| New | +$8.29M | 0.2% | 88 |
|
Other funds holding CVS
Veritable's CVS Position: Q3 2023 in Review
Veritable sold out of CVS Health (CVS) in Q3 2023, closing a stake of 48,224 shares — an estimated $3.33M sold.
Veritable first reported a position in CVS in Q2 2013 and held it in 41 quarters. The position peaked at $11.6M in Q1 2015. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Veritable reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
- Veritable sold 48,224 CVS Health shares in Q3 2023, an estimated $3.33M.
- Veritable first reported a position in CVS Health in Q2 2013 and held it in 41 quarters.
- Veritable's CVS Health position peaked at $11.6M in Q1 2015.
- 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Veritable's 13F filing for Q3 2023.